Product Images Tizanidine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Tizanidine Hydrochloride NDC 60505-2648 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
2mg-150btl - 2mg 150btl
This appears to be medication packaging information for Tizanidine Hydrochloride Capsules. Each capsule contains 2.288 grams of Tizanidine Hydrochloride USP and 0.192 grams of Zanaflex. The capsules should be stored between 68 and 77 degrees Fahrenheit, and should be dispensed in a high-density container with a child-resistant closure. The recommended dosage should be followed according to the package instructions. Zanaflex is a registered trademark of Acorda Therapeutics. The package contains 150 capsules and has an NDC number of 60505-2648-7.*
4mg-150btl - 4mg 150btl
Each capsule of Tizanidine Hydrochloride contains 4576mg of Tizanidine and is a USP (substance). It also contains 194g of zandin base. It is stored at a controlled temperature of 50°C (8°F) and has a limited prescription of 558 USP Corirollsd Foom Temperstur. It is dispensed in containers with instand colors and dosage should be as per package instruction. Tizanidine is a registered trademark of Acorca Therapeutcs. The given text seems to be a packaging label of a medicine with 150 capsules.*
6mg-150btl - 6mg 150btl
This appears to be a label of medication containing Tizanidine Hydrochloride Capsules. Each container has 150 capsules with a usual dosage mentioned on the package. The USP (United States Pharmacopeia) is mentioned with the weight of the medicine. The package has a registered trademark of Acorca Therapeutcs with a specific NDC (National Drug Code) for regulating the drug in the USA. The rest of the text seems to be technical information regarding dispensing and storing the medication.*
ChemicalStructure - Chemical Structure
Figure2 - Figure 2
Figure3 - Figure 3
The text describes an improvement in Ashworth Score through the use of Tizanidine, with a mean dose of 26.8 mg. The study used an end of titration, end of maintenance, and endpoint approach, with observations conducted during week 3 and week 7.*
Figure1 - Figure1
This text seems to be displaying a timeline that represents different hours after a medication (T2) has been administered. The hours displayed are 14, 16, and 18. The term "Hours from Dosing" indicates that these hours represent the time elapsed since the medication was administered. The number 0 could possibly represent the initial moment when the medication was administered, but more context is needed to conclude that with confidence.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.